Abstract:Chinese hamster ovary (CHO) cells are the most widely used mammalian hosts for recombinant protein production. However, by conventional random integration strategy, development of a high-expressing and stable recombinant CHO cell line has always been a difficult task due to the heterogenic insertion and its caused requirement of multiple rounds of selection. Site-specific integration of transgenes into CHO hot spots is an ideal strategy to overcome these challenges since it can generate isogenic cell lines with consistent productivity and stability. In this study, we investigated three sites with potential high transcriptional activities: C12orf35, HPRT, and GRIK1, to determine the possible transcriptional hot spots in CHO cells, and further construct a reliable site-specific integration strategy to develop recombinant cell lines efficiently. Genes encoding representative proteins mCherry and anti-PD1 monoclonal antibody were targeted into these three loci respectively through CRISPR/Cas9 technology. Stable cell lines were generated successfully after a single round of selection. In comparison with a random integration control, all the targeted integration cell lines showed higher productivity, among which C12orf35 locus was the most advantageous in both productivity and cell line stability. Binding affinity and N-glycan analysis of the antibody revealed that all batches of product were of similar quality independent on integrated sites. Deep sequencing demonstrated that there was low level of off-target mutations caused by CRISPR/Cas9, but none of them contributed to the development process of transgene cell lines. Our results demonstrated the feasibility of C12orf35 as the target site for exogenous gene integration, and strongly suggested that C12orf35 targeted integration mediated by CRISPR/Cas9 is a reliable strategy for the rapid development of recombinant CHO cell lines.

Establishment and characterization of CHO cell line stably expressing human CCR5 gene

Establishment of A New Cell Line for High-Throughput Evaluation of Chemokine Ccr5 Receptor Antagonists

Construction and Characterization of Plasmid Expressing Human CCR5 Gene in Eukaryotes

High Level Expression, Purification and Characterization of Recombinant CCR5 As a Vaccine Candidate Against HIV.

Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.

Chemokine Receptor Ccr5 Functionally Couples to Inhibitory G Proteins and Undergoes Desensitization

[Expression and Function Analysis of Chemokine Receptor CCR6 in HEK293 Cells].

Clone of HIV-1 p24 gene and the pilot study of its toxicity to Chinese hamster ovary cells

Construction and Purification of the Recombinant Adenoviral Vector Carrying Antisense RNA to Chemokine Receptor CCR5

[Establishment of a Transgenic Cell Line with Stable Expression of Human CD14].

CCR5 Editing by Staphylococcus Aureus Cas9 in Human Primary CD4+ T Cells and Hematopoietic Stem/progenitor Cells Promotes HIV-1 Resistance and CD4+ T Cell Enrichment in Humanized Mice

Construction of Recombinant Vectors Expressing Antisense RNA to CCR5 and Expression in Eukaryotic Cells

Construction and Identification of Artificial Mirna Targeting to HIV-1 Cell Receptor Gene CCR5

Effect of CCR5Delta32 Gene Expression in Human Peripheral Blood Mononuclear cells(PBMC)on Proliferation Function of the PBMC

Molecular Cloning and Functional Expression of Human Chemokine Receptor CCR4

Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35

High Level Expression Human Chemokine Receptor CCR- 5 in Fission Yeast

Why CCR5 is Chosen As the Target for Stem Cell Gene Therapy for HIV Infection?

Advances of CCR5 antagonists: From small molecules to macromolecules

InducingCCR5 Delta 32/delta 32 Homozygotes in the Human Jurkat CD4+Cell Line and Primary CD4+Cells by CRISPR-Cas9 Genome-Editing Technology

Targeting CCR5 for anti-HIV research